{"transactions":[{"id":706701,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2028-11-20","underlying":"Common Stock","underlying_shares":5468},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706700,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2027-11-21","underlying":"Common Stock","underlying_shares":1894},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706699,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2026-12-08","underlying":"Common Stock","underlying_shares":1414},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706698,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":22.77,"expiration_date":"2032-11-20","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706697,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":21.12,"expiration_date":"2031-11-21","underlying":"Common Stock","underlying_shares":23248},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706696,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":14.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":29524},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706695,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":18.59,"expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706694,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.07,"expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706693,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.42,"expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706692,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.64,"expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":706691,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-07-17T20:15:55.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":383314,"price":31.5,"value":12074391.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the \"Merger\")"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001161697-26-000184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169726000184/form4.xml","form_type":"4"}},{"id":957124,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-30T22:00:25.000Z","date":"2025-12-29","kind":"exercise","planned":false,"acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 29, 2025."}],"balance_after":178163,"derivative":{"underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001161697-25-000496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000496/form4.xml","form_type":"4"}},{"id":957123,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-30T22:00:25.000Z","date":"2025-12-29","kind":"exercise","planned":false,"acquired":true,"shares":1334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":383314,"source":{"system":"sec-edgar","filing":"0001161697-25-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000496/form4.xml","form_type":"4"}},{"id":974321,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-10T22:00:39.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":false,"shares":1413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025."}],"balance_after":179497,"derivative":{"underlying":"Common Stock","underlying_shares":1413},"source":{"system":"sec-edgar","filing":"0001161697-25-000451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000451/form4.xml","form_type":"4"}},{"id":974320,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-10T22:00:39.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":true,"shares":1413,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":381980,"source":{"system":"sec-edgar","filing":"0001161697-25-000451","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000451/form4.xml","form_type":"4"}},{"id":989816,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-25T01:08:30.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026, and 1/3rd on November 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on November 21, 2025."}],"balance_after":180910,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0001161697-25-000424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000424/form4.xml","form_type":"4"}},{"id":989815,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-25T01:08:30.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":5468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":181857,"derivative":{"underlying":"Common Stock","underlying_shares":5468},"source":{"system":"sec-edgar","filing":"0001161697-25-000424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000424/form4.xml","form_type":"4"}},{"id":989814,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2025-11-25T01:08:30.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028."}],"balance_after":176389,"derivative":{"exercise_price":22.77,"expiration_date":"2032-11-20","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001161697-25-000424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000424/form4.xml","form_type":"4"}},{"id":989813,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-11-25T01:08:30.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":947,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":380567,"source":{"system":"sec-edgar","filing":"0001161697-25-000424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000424/form4.xml","form_type":"4"}},{"id":1053503,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2025-08-28T21:00:43.000Z","date":"2025-08-27","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vested in three annual tranches beginning on December 19, 2019."}],"balance_after":158274,"derivative":{"exercise_price":2.24,"expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-25-000302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000302/form4.xml","form_type":"4"}},{"id":1053502,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-08-28T21:00:43.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":26000,"price":20.2,"value":525200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market to fund the exercise price and estimated taxes due from Reporting Person as a result of the exercise of the stock options reported on Table II."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price for the shares sold. Shares were sold in a range from $20.10 to $20.32 per share."}],"balance_after":379620,"source":{"system":"sec-edgar","filing":"0001161697-25-000302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000302/form4.xml","form_type":"4"}},{"id":1053501,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-08-28T21:00:43.000Z","date":"2025-08-27","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":2.24,"value":112000.0,"ownership":{"direct":true},"balance_after":405620,"source":{"system":"sec-edgar","filing":"0001161697-25-000302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000302/form4.xml","form_type":"4"}},{"id":1259367,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:00:31.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on February 14, 2025."}],"balance_after":208274,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-25-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000073/form4.xml","form_type":"4"}},{"id":1259366,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-02-19T22:00:31.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":355620,"source":{"system":"sec-edgar","filing":"0001161697-25-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169725000073/form4.xml","form_type":"4"}},{"id":1319772,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-31T21:30:19.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 27, 2024."}],"balance_after":212274,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-24-000545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000545/form4.xml","form_type":"4"}},{"id":1319771,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-12-31T21:30:19.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":351620,"source":{"system":"sec-edgar","filing":"0001161697-24-000545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000545/form4.xml","form_type":"4"}},{"id":1335351,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-11T22:00:24.000Z","date":"2024-12-09","kind":"exercise","planned":false,"acquired":false,"shares":1413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024."}],"balance_after":213607,"derivative":{"underlying":"Common Stock","underlying_shares":1413},"source":{"system":"sec-edgar","filing":"0001161697-24-000509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000509/form4.xml","form_type":"4"}},{"id":1335350,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-12-11T22:00:24.000Z","date":"2024-12-09","kind":"exercise","planned":false,"acquired":true,"shares":1413,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":350287,"source":{"system":"sec-edgar","filing":"0001161697-24-000509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000509/form4.xml","form_type":"4"}},{"id":1352537,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-11-25T22:01:02.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":2841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":215020,"derivative":{"underlying":"Common Stock","underlying_shares":2841},"source":{"system":"sec-edgar","filing":"0001161697-24-000484","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000484/form4.xml","form_type":"4"}},{"id":1352536,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2024-11-25T22:01:02.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":23248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027."}],"balance_after":212179,"derivative":{"exercise_price":21.12,"expiration_date":"2031-11-21","underlying":"Common Stock","underlying_shares":23248},"source":{"system":"sec-edgar","filing":"0001161697-24-000484","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000484/form4.xml","form_type":"4"}},{"id":1424143,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2024-08-23T21:00:13.000Z","date":"2024-08-22","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three annual tranches beginning on January 2, 2019."}],"balance_after":188931,"derivative":{"exercise_price":4.01,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001161697-24-000375","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000375/form4.xml","form_type":"4"}},{"id":1424142,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-08-23T21:00:13.000Z","date":"2024-08-21","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":20.097,"value":301455.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share."}],"balance_after":348874,"source":{"system":"sec-edgar","filing":"0001161697-24-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000375/form4.xml","form_type":"4"}},{"id":1424141,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-08-23T21:00:13.000Z","date":"2024-08-21","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":4.01,"value":60150.0,"ownership":{"direct":true},"balance_after":363874,"source":{"system":"sec-edgar","filing":"0001161697-24-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000375/form4.xml","form_type":"4"}},{"id":1543640,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2024-04-10T21:15:34.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three annual tranches beginning on January 2, 2019."}],"balance_after":203931,"derivative":{"exercise_price":4.01,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001161697-24-000194","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000194/form4.xml","form_type":"4"}},{"id":1543639,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-04-10T21:15:34.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":15.68,"value":392000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.55 to $15.77 per share."}],"balance_after":348874,"source":{"system":"sec-edgar","filing":"0001161697-24-000194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000194/form4.xml","form_type":"4"}},{"id":1543638,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-04-10T21:15:34.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":4.01,"value":100250.0,"ownership":{"direct":true},"balance_after":373874,"source":{"system":"sec-edgar","filing":"0001161697-24-000194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000194/form4.xml","form_type":"4"}},{"id":1637982,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-16T22:01:00.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on February 15, 2024."}],"balance_after":228931,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-24-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000106/form4.xml","form_type":"4"}},{"id":1637981,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2024-02-16T22:01:00.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":348874,"source":{"system":"sec-edgar","filing":"0001161697-24-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000106/form4.xml","form_type":"4"}},{"id":1691651,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2024-01-03T22:19:04.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vested in three annual tranches beginning on January 3, 2018."}],"balance_after":232931,"derivative":{"exercise_price":1.13,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001161697-24-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000027/form4.xml","form_type":"4"}},{"id":1691650,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2024-01-03T22:19:04.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":1.13,"value":11300.0,"ownership":{"direct":true},"balance_after":344874,"source":{"system":"sec-edgar","filing":"0001161697-24-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169724000027/form4.xml","form_type":"4"}},{"id":1697854,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-29T22:00:22.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023."}],"balance_after":242931,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-23-000653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000653/form4.xml","form_type":"4"}},{"id":1697853,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2023-12-29T22:00:22.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":334874,"source":{"system":"sec-edgar","filing":"0001161697-23-000653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000653/form4.xml","form_type":"4"}},{"id":1710826,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-12-14T22:00:09.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three annual tranches beginning on January 3, 2018."}],"balance_after":244264,"derivative":{"exercise_price":1.13,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-23-000623","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000623/form4.xml","form_type":"4"}},{"id":1710825,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2023-12-14T22:00:09.000Z","date":"2023-12-12","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":13.325,"value":666250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market for personal reasons, and to fund the exercise price for stock options expiring on January 3, 2024, and not as a result of any disagreement with the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.30 to $13.36 per share."}],"balance_after":333541,"source":{"system":"sec-edgar","filing":"0001161697-23-000623","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000623/form4.xml","form_type":"4"}},{"id":1710824,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2023-12-14T22:00:09.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.13,"value":56500.0,"ownership":{"direct":true},"balance_after":383541,"source":{"system":"sec-edgar","filing":"0001161697-23-000623","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000623/form4.xml","form_type":"4"}},{"id":1714016,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-12T22:00:46.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":4240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":294264,"derivative":{"underlying":"Common Stock","underlying_shares":4240},"source":{"system":"sec-edgar","filing":"0001161697-23-000618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000618/form4.xml","form_type":"4"}},{"id":1714015,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-12-12T22:00:46.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":29524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026."}],"balance_after":290024,"derivative":{"exercise_price":14.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":29524},"source":{"system":"sec-edgar","filing":"0001161697-23-000618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000618/form4.xml","form_type":"4"}},{"id":1894874,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-05-12T21:01:05.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 15, 2016 and previously vested in two annual installments."}],"balance_after":260500,"derivative":{"exercise_price":0.79,"expiration_date":"2023-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-23-000287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000287/form4.xml","form_type":"4"}},{"id":1894873,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2023-05-12T21:01:05.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0.79,"value":15800.0,"ownership":{"direct":true},"balance_after":333541,"source":{"system":"sec-edgar","filing":"0001161697-23-000287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000287/form4.xml","form_type":"4"}},{"id":1922920,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-04-07T21:00:21.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on June 15, 2016 and previously vested in two annual installments."}],"balance_after":280500,"derivative":{"exercise_price":0.79,"expiration_date":"2023-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-23-000243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000243/form4.xml","form_type":"4"}},{"id":1922919,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2023-04-07T21:00:21.000Z","date":"2023-04-05","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":16.83,"value":504900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold."}],"balance_after":313541,"source":{"system":"sec-edgar","filing":"0001161697-23-000243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000243/form4.xml","form_type":"4"}},{"id":1922918,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2023-04-07T21:00:21.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":0.79,"value":23700.0,"ownership":{"direct":true},"balance_after":343541,"source":{"system":"sec-edgar","filing":"0001161697-23-000243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000243/form4.xml","form_type":"4"}},{"id":1956646,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T11:54:53.000Z","date":"2023-03-09","kind":"purchase","acquired":true,"shares":5000,"price":4.1463,"value":20731.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10835,"source":{"system":"sec-edgar","filing":"0001437749-23-006276","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923006276/rdgdoc.xml","form_type":"4"}},{"id":2007185,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-17T22:00:45.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 15, 2023."}],"balance_after":310500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-23-000135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000135/form4.xml","form_type":"4"}},{"id":2007184,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2023-02-17T22:00:45.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":313541,"source":{"system":"sec-edgar","filing":"0001161697-23-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169723000135/form4.xml","form_type":"4"}},{"id":2074859,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-29T21:50:14.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":314500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-22-000612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000612/form4.xml","form_type":"4"}},{"id":2074858,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-12-29T21:50:14.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."}],"balance_after":310500,"derivative":{"exercise_price":18.59,"expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001161697-22-000612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000612/form4.xml","form_type":"4"}},{"id":2092104,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-08T22:05:11.000Z","date":"2022-12-06","kind":"exercise","acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022."}],"balance_after":295500,"derivative":{"underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001161697-22-000578","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000578/form4.xml","form_type":"4"}},{"id":2092103,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2022-12-08T22:05:11.000Z","date":"2022-12-06","kind":"exercise","acquired":true,"shares":1334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":309541,"source":{"system":"sec-edgar","filing":"0001161697-22-000578","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000578/form4.xml","form_type":"4"}},{"id":2175995,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-08-23T21:01:30.000Z","date":"2022-08-22","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on December 30, 2015 and previously vested in two annual installments."}],"balance_after":296834,"derivative":{"exercise_price":2.53,"expiration_date":"2022-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-22-000413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000413/form4.xml","form_type":"4"}},{"id":2175994,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-08-23T21:01:30.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":20000,"price":14.159,"value":283180.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Tierney has advised the Company that the sale of shares was to pay the exercise cost of the shares and to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were sold in various lots from $14.15 to $14.20 per share. The listed sales price represents A weighted average price for the shares sold."}],"balance_after":308207,"source":{"system":"sec-edgar","filing":"0001161697-22-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000413/form4.xml","form_type":"4"}},{"id":2175993,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-08-23T21:01:30.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":20000,"price":2.53,"value":50600.0,"ownership":{"direct":true},"balance_after":328207,"source":{"system":"sec-edgar","filing":"0001161697-22-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000413/form4.xml","form_type":"4"}},{"id":2218639,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T21:20:34.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-016303","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922016303/rdgdoc.xml","form_type":"4"}},{"id":2255112,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-27T00:30:06.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":2000,"price":4.39,"value":8780.0,"ownership":{"direct":true},"balance_after":5835,"source":{"system":"sec-edgar","filing":"0001437749-22-013706","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922013706/rdgdoc.xml","form_type":"4"}},{"id":2258144,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-05-24T20:30:27.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on December 30, 2015 and previously vested in two annual installments."}],"balance_after":252333,"derivative":{"exercise_price":2.53,"expiration_date":"2022-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-22-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000261/form4.xml","form_type":"4"}},{"id":2258143,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-05-24T20:30:27.000Z","date":"2022-05-20","kind":"sale","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Tierney has advised the Company that the sale of shares was to pay the exercise cost of the shares and to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"12,803 shares were sold at a price of $7.03 per share, 5,626 were sold at a price of $7.04 per share, and 1,571 were sold at a price of $7.05 per share."}],"balance_after":308207,"source":{"system":"sec-edgar","filing":"0001161697-22-000261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000261/form4.xml","form_type":"4"}},{"id":2258142,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-05-24T20:30:27.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":20000,"price":2.53,"value":50600.0,"ownership":{"direct":true},"balance_after":328207,"source":{"system":"sec-edgar","filing":"0001161697-22-000261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000261/form4.xml","form_type":"4"}},{"id":2391560,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-16T22:05:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person within sixty (60) days of vesting."}],"balance_after":336834,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001161697-22-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169722000122/form4.xml","form_type":"4"}},{"id":2456078,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-12-30T21:50:58.000Z","date":"2021-12-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 28, 2022, 1/3rd on December 28, 2023 and 1/3rd on December 28, 2024."}],"balance_after":324834,"derivative":{"exercise_price":7.07,"expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-21-000622","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000622/form4.xml","form_type":"4"}},{"id":2483579,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-06T22:13:58.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 3, 2021."}],"balance_after":304834,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-21-000557","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000557/form4.xml","form_type":"4"}},{"id":2483578,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2021-12-06T22:13:58.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":308207,"source":{"system":"sec-edgar","filing":"0001161697-21-000557","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000557/form4.xml","form_type":"4"}},{"id":2491996,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-30T21:10:31.000Z","date":"2021-11-30","kind":"purchase","acquired":true,"shares":2000,"price":7.789,"value":15578.0,"ownership":{"direct":true},"balance_after":3835,"source":{"system":"sec-edgar","filing":"0001437749-21-027552","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921027552/rdgdoc.xml","form_type":"4"}},{"id":2599791,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-08-17T20:48:59.000Z","date":"2021-08-13","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on August 28, 2014 and previously vested in two equal annual installments."}],"balance_after":306167,"derivative":{"exercise_price":3.12,"expiration_date":"2021-08-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-21-000383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000383/form4.xml","form_type":"4"}},{"id":2599790,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2021-08-17T20:48:59.000Z","date":"2021-08-13","kind":"sale","acquired":false,"shares":50000,"price":6.0779,"value":303895.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Tierney has advised the Company that the sale of shares was to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company."}],"balance_after":306874,"source":{"system":"sec-edgar","filing":"0001161697-21-000383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000383/form4.xml","form_type":"4"}},{"id":2599789,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2021-08-17T20:48:59.000Z","date":"2021-08-13","kind":"exercise","acquired":true,"shares":50000,"price":3.12,"value":156000.0,"ownership":{"direct":true},"balance_after":356874,"source":{"system":"sec-edgar","filing":"0001161697-21-000383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000383/form4.xml","form_type":"4"}},{"id":2660763,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T12:36:09.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 17, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's sixth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.47,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-015183","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921015183/rdgdoc.xml","form_type":"4"}},{"id":2925340,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-04T21:42:21.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 30, 2021, 1/3rd on December 30, 2022 and 1/3rd on December 30, 2023."}],"balance_after":356167,"derivative":{"exercise_price":3.42,"expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-21-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169721000025/form4.xml","form_type":"4"}},{"id":2932700,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-23T23:15:47.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 22, 2020."}],"balance_after":326167,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-20-000590","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169720000590/form4.xml","form_type":"4"}},{"id":2932699,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, Par Value $0.001 per share","published_at":"2020-12-23T23:15:47.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":306874,"source":{"system":"sec-edgar","filing":"0001161697-20-000590","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169720000590/form4.xml","form_type":"4"}},{"id":3054096,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-18T20:59:55.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":1000,"price":0.665,"value":665.0,"ownership":{"direct":true},"balance_after":29372,"source":{"system":"sec-edgar","filing":"0001437749-20-018283","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920018283/rdgdoc.xml","form_type":"4"}},{"id":3054095,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-18T20:59:55.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":4500,"price":0.66,"value":2970.0,"ownership":{"direct":true},"balance_after":28372,"source":{"system":"sec-edgar","filing":"0001437749-20-018283","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920018283/rdgdoc.xml","form_type":"4"}},{"id":3054094,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-18T20:59:55.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":2000,"price":0.645,"value":1290.0,"ownership":{"direct":true},"balance_after":23872,"source":{"system":"sec-edgar","filing":"0001437749-20-018283","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920018283/rdgdoc.xml","form_type":"4"}},{"id":3054093,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-18T20:59:55.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":2500,"price":0.6427,"value":1606.75,"ownership":{"direct":true},"balance_after":21872,"source":{"system":"sec-edgar","filing":"0001437749-20-018283","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920018283/rdgdoc.xml","form_type":"4"}},{"id":3103030,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-06-23T00:44:02.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the OTCQB Venture Market on the date of grant, June 19, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's fourth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.271,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-20-013591","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920013591/rdgdoc.xml","form_type":"4"}},{"id":3352362,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-12-04T22:20:43.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":327500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-19-000516","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169719000516/form4.xml","form_type":"4"}},{"id":3352361,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-04T22:20:43.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."}],"balance_after":323500,"derivative":{"exercise_price":4.64,"expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001161697-19-000516","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169719000516/form4.xml","form_type":"4"}},{"id":3471089,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-02T21:04:40.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":6428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a fully vested restricted stock award (\"RSA\") under the Issuer's 2014 Equity Incentive Plan. The RSA was granted to the Reporting Person in lieu of the quarterly cash compensation payable to the Reporting Person pursuant to the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":19372,"source":{"system":"sec-edgar","filing":"0001437749-19-013393","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919013393/rdgdoc.xml","form_type":"4"}},{"id":3489385,"issuer":{"id":110330,"kind":"organization","name":"Timber Pharmaceuticals, Inc.","symbol":"TMBR"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres and CEO"}}],"security":"Option to purchase common stock","published_at":"2019-06-14T20:54:43.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":360000,"price":0.84,"value":302400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option vests and becomes exercisable ratably over 36 months"}],"balance_after":360000,"derivative":{"exercise_price":0.84,"exercise_date":"2019-07-31","expiration_date":"2029-06-12","underlying":"Common stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001424422-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000142442219000007/primary_doc.xml","form_type":"4"}},{"id":3527555,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-15T00:39:10.000Z","date":"2019-05-10","kind":"grant","acquired":true,"shares":6944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a fully vested restricted stock award (\"RSA\") under the Issuer's 2014 Equity Incentive Plan. The RSA was granted to the Reporting Person in lieu of the quarterly cash compensation payable to the Reporting Person pursuant to the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":12944,"source":{"system":"sec-edgar","filing":"0001437749-19-009881","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919009881/rdgdoc.xml","form_type":"4"}},{"id":3547511,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-04-26T21:05:27.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, April 24, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's third amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.62,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-19-008069","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919008069/rdgdoc.xml","form_type":"4"}},{"id":3721109,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:46:42.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":290000,"derivative":{"exercise_price":2.24,"exercise_date":"2019-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001161697-18-000621","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169718000621/form4.xml","form_type":"4"}},{"id":3721108,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:46:42.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":265000,"derivative":{"exercise_price":2.24,"exercise_date":"2018-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001161697-18-000621","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169718000621/form4.xml","form_type":"4"}},{"id":3810567,"issuer":{"id":110330,"kind":"organization","name":"Timber Pharmaceuticals, Inc.","symbol":"TMBR"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-20T20:01:12.000Z","date":"2018-09-19","kind":"purchase","acquired":true,"shares":100000,"price":0.2025,"value":20250.0,"ownership":{"direct":true},"balance_after":7500000,"source":{"system":"sec-edgar","filing":"0001104659-18-057805","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000110465918057805/a4.xml","form_type":"4"}},{"id":3816844,"issuer":{"id":110330,"kind":"organization","name":"Timber Pharmaceuticals, Inc.","symbol":"TMBR"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase common stock","published_at":"2018-09-13T21:14:36.000Z","date":"2018-09-11","kind":"grant","acquired":true,"shares":7400000,"price":0.22,"value":1628000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option vests as to 25% of the shares subject to the option on the first anniversary date of the grant with an additional 1/36th of the remaining shares vesting monthly thereafter."}],"balance_after":7400000,"derivative":{"exercise_price":0.22,"exercise_date":"2019-09-11","expiration_date":"2028-09-11","underlying":"Common stock","underlying_shares":7400000},"source":{"system":"sec-edgar","filing":"0001424422-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000142442218000004/primary_doc.xml","form_type":"4"}},{"id":3918541,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T20:06:27.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, May 22, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.1,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-18-010654","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918010654/rdgdoc.xml","form_type":"4"}},{"id":4107227,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-04T21:58:06.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":240000,"derivative":{"exercise_price":4.01,"exercise_date":"2019-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-18-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169718000038/form4.xml","form_type":"4"}},{"id":4107226,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-04T21:58:06.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":220000,"derivative":{"exercise_price":4.01,"exercise_date":"2018-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-18-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169718000038/form4.xml","form_type":"4"}},{"id":4165299,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-11-13T21:20:57.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":145000,"derivative":{"exercise_price":0.47,"exercise_date":"2012-12-12","expiration_date":"2017-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-17-000492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169717000492/form4.xml","form_type":"4"}},{"id":4165298,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2017-11-13T21:20:57.000Z","date":"2017-11-09","kind":"tax_withholding","acquired":false,"shares":7860,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Holder exercised 50,000 options at $0.47 per share via cashless exercise and was issued 42,140 shares  based on the November 8, 2017 closing price of $2.99 per share."}],"balance_after":305541,"source":{"system":"sec-edgar","filing":"0001161697-17-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169717000492/form4.xml","form_type":"4"}},{"id":4165297,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29734,"kind":"person","name":"Tierney David S","position":1,"cik":"0001292636","reported_name":"Tierney David S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2017-11-13T21:20:57.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":50000,"price":0.47,"value":23500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Holder exercised 50,000 options at $0.47 per share via cashless exercise and was issued 42,140 shares  based on the November 8, 2017 closing price of $2.99 per share."}],"balance_after":313401,"source":{"system":"sec-edgar","filing":"0001161697-17-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292636/000116169717000492/form4.xml","form_type":"4"}}],"next_cursor":"2017-11-13T21:20:57.000000Z,4165297"}